蕭聖謀主任

  1. Ting WH, Chen HH, Hsieh SW, Wei MC, Hsiao SM*. Comparison of Clinical Outcomes in Women with Surgically Treated Early Primary Cervical Cancer: Lymphadenectomy versus Sentinel Lymph Node Biopsy. J Chin Med Assoc. 2025;88(3):238-45. (IF = 1.9; R/C = 104/325)
  2. Hsiao SM*, Wu WY, Lin HH. Predictors of the Efficacy of CO2 Laser Therapy for Female Stress Urinary Incontinence. J Chin Med Assoc. 2025;88(2):145-50. (IF = 1.9; R/C = 105/329)
  3. Wu CJ, Hsiao SM, Wu PC, Chang TC, Chen CH, Sheu BC, Lin HH*. Prevalence and predictors of detrusor underactivity and bladder outlet obstruction in women with lower urinary tract symptoms. Sci Rep. 2024;14:25141.  (IF = 3.8; R/C = 25/134)
  4. Wu PC#, Hsiao SM#, Lin HH*. Age-specific prevalence, clinical and urodynamic findings of detrusor underactivity and bladder outlet obstruction in female voiding dysfunction. Int J Gynaecol Obstet. 2024;167:797-803.  (IF = 2.6; R/C = 41/136)
  5. Ting WH, Chen HH, Wei MC, Sun HD, Hsiao SM*. Intraperitoneal Chemotherapy without Bevacizumab versus Intravenous Chemotherapy with Bevacizumab as the Frontline Adjuvant Therapy in Advanced Ovarian Cancer. Cancers 2024;16(3382):1-11.  (IF = 4.5; R/C = 78/322)
  6. Wu PC#, Hsiao SM#, Lin HH*. The prevalence of overt, occult, and no-demonstrated stress urinary incontinence and their clinical and urodynamic findings in women with advanced-stage cystoceles. J Formos Med Assoc. 2024;123:1064-9.  (IF = 2.6; R/C = 70/325)
  7. Hsiao SM*, Chang SR. Response to letter to the editor “Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function” J Formos Med Assoc. 2024(inpress) (IF = 2.6; R/C = 70/325)
  8. Liang CJ, Hsiao SM*. Crizotinib for refractory vulvar malignant melanoma with equivocal MET amplification: A Case Report. Taiwan J Obstet Gynecol. 2024(inpress) (IF = 2.0; R/C = 63/136)
  9. Chung CH#, Tsai CC#, Hsiao FW, Chen HH , Ting WH, Hsiao SM*. Predictors of Infused Distending Fluid Volume in Hysteroscopic Myomectomy. Medicina. 2024;60(1424):1-10. (IF = 2.4; R/C = 80/325)
  10. Hsiao SM*. Predictors of non-persistence in women with overactive bladder syndrome. Sci Rep. 2024;14(1):7499.  (IF = 4.6; R/C = 22/73)
  11. Hsiao SM*, Chang SR. Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function. J Formos Med Assoc. 2024;123:710-15. (IF = 3.2; R/C = 72/169)
  12. Hsiao SM*, Liao SC. Effect of tibolone vs hormone replacement therapy on climacteric symptoms and
    psychological distress. J Chin Med Assoc. 2024;87(2):189-95. (IF = 3.0; R/C = 78/169)
  13. Ting WH, Hsiao SM, Sun HD*. Conservative management of cesarean scar pregnancy with two-doses systemic methotrexate and hysteroscopy. Asian J Surg. 2023;46:2239-2240. (IF = 2.808; R/C = 88/213)
  14. Sun HD, Peng FH, Hsiao SM, Wang PH. A small mature cystic ovarian teratoma associated with anti-NMDA receptor encephalitis and acute respiratory failure: A case report. Taiwan J Obstet Gynecol. 2023;62:765-8. (IF = 2.1; R/C = 57/85)
  15. Hsiao SM, Lin HH*. Feasibility and clinical implications of 3-day bladder diary derived classification of female storage lower urinary tract symptoms. Scientific Reports 2022;12:20339. (IF = 4.997; R/C = 19/74)
  16. Hsiao SM#, Tu FC#, Su TC, Wu PC, Lin HH*. Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial. Scientific Reports 2022;12(14219):1-8. (IF = 4.997; R/C = 19/74)
  17. Wu PC#, Hsiao SM#, Chang TC, Chen CH, Lin HH*. Clinical outcome and urodynamic changes of tailored transvaginal mesh surgery for pelvic organ prolapse: A mid-term 40 Months follow-up. J Formos Med Assoc 2022;121:2424-9. (IF = 3.871; R/C = 61/172)
  18. Wu LC#, Peng FS#, Cheung Leung, Lu HF, Lin HH, Hsiao SM*. Comparison of cesarean section rates between obstetricians preferring labor induction at early versus late gestational age. Taiwan J Obstet Gynecol 2022;61(5):847-53. (IF = 1.944; R/C = 72/85)
  19. Huang PH#, Tsai MC#, Ting WH, Chen HH, Lin HH, Hsiao SM*. Predictors of Surgical Outcomes of Laparoscopic Myomectomy with Barbed Sutures: Comparison of V-Loc and Quill Barbed Sutures. Int J Gynaecol Obstet 2022;158(3):757-9. (IF = 4.447; R/C = 17/85)
  20. Wu CY#, Tseng LM#, Chen HH, Hsieh CH, Hsiao SM*. Fatal Rectovaginal Fistula in Post-Radiotherapy Locally Advanced Cervical Cancer Patients. Taiwan J Obstet Gynecol 2022;61(6):1069-72. (IF = 1.944; R/C = 72/85)
  21. Yang SP#, Chen HH#, Peng FH**, Hsiao SM*. Obstetric measures to decrease the spread of SARS-CoV-2 infection during labor in a conventional labor room. Taiwan J Obstet Gynecol 2022;61:568-9. (IF = 1.705; R/C = 72/83)
  22. Chen HH#, Hou PY#, Ting WH, Shueng PW*, Hsiao SM*. Feasibility and Safety of Intraoperative Radiotherapy with Low Energy X‐ray Photon Therapy for Recurrent Gynecological Cancer: A Case Series. Life 2022;12(685):1-11. (IF = 3.817; R/C = 27/93)
  23. Ting WH#, Hsieh SW#, Chen HH, Wei MC, Lin HH, Hsiao SM*. Predictors for the Recurrence of Clinically Uterine-Confined Endometrial Cancer and the Role of Cytokeratin Immunohistochemistry Stain in the Era of Sentinel Lymph Node Mapping. Cancers 2022;14:1-13. (IF = 6.639; R/C = 51/242)
  24. Wu PC, Hsiao SM, Lin HH* Prevalence and predictors of nocturnal polyuria in females with overactive bladder syndrome. World J Urol. 2022;40:519-27. (IF = 4.226; R/C = 21/89)
  25. Huang PH, Chen YY, Chen HH, Ting WH, Lin HH, Chen KH**, Hsiao SM*. Factors Affecting Clinical Outcomes in Women with Non-gastric Gastrointestinal Stromal Tumors. Taiwan J Obstet Gynecol 2022;61:306-11. (IF = 1.705; R/C = 72/83)
  26. Lin TH, Tu FC, Lin HH, Hsiao SM*. Predictors of Clinical Outcome in Women with Pelvic Organ Prolapse Who Underwent Transvaginal Mesh Reconstruction Surgery. Medicina. 2022;58(148):1-14. (IF = 2.430; R/C = 80/167)
  27. Liu HM, Lin HH,  Hsiao SM*. Predictors of cure and overactive bladder syndrome after a mid-urethral sling procedure in women with stress urinary incontinence. Maturitas. 2022;156:18-24.  (IF = 4.342; R/C = 12/83)
  28. Wang HF, Chen HH, Ting WH, Lu HF, Lin HH, Hsiao SM*. Robotic or Laparoscopic Treatment of Cesarean Scar Defects or Cesarean Scar Pregnancies with a Uterine Sound Guidance. Taiwan J Obstet Gynecol 2021;60:821-6. (IF = 1.705; R/C = 72/83)
  29. Hsiao SM, Kuo HC. Predictors of further anti-incontinence interventions or transvaginal urethrolysis after a pubovaginal  sling procedure in women with and without neurologic disorders. J Formos Med Assoc. 2021;120;1464-77. (IF = 3.008; R/C = 42/165)
  30. Chang TC, Wu PC, Hsiao SM, Lin HH. Prevalence of detrusor underactivity and bladder outlet obstruction in women with cystocele and changes in voiding function after cystocele repair. J Formos Med Assoc 2020;10.1016.  (IF = 3.008; R/C = 42/165)
  31. Wu WY, Hsiao SM#, Wu PC, Lin HH. Test-retest reliability of the 20-min pad test with infusion of strong-desired volume in the bladder for female urodynamic stress incontinence. Sci Rep. 2020;10(1):18472. (IF = 4.011; R/C = 15/69)
  32. Chen HH, Ting WH, Sun HD, Wei MC, Lin HH, Hsiao SM*. Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy. Int J Environ Res Public Health. 2020;17:5941. (IF = 2.849; R/C = 32/170)
  33. Liu YL, Ting WH, Hsiao SM, Huang CM, Wu WY. Efficacy of bio-assisted pelvic floor muscle training in women with pelvic floor dysfunction. Eur J Obstet Gynecol Reprod Biol. 2020;251:206-11. (IF = 2.024; R/C = 44/83)
  34. Ting WH, Hsiao CH, Chen HH, Wei MC, Lin HH, Hsiao SM*. Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline Intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab. Int.J.Environ.Res.Public Health  2020;17(3603):10.3390 (IF = 2.468; R/C = 67/186)
  35. Hsiao SM*. Letter to the Editor on "A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy" Eur J Obstet Gynecol Reprod Biol 2020;247:257-71. (IF = 2.024; R/C = 44/183)
  36. Hsiao SM*, Shih JC, Lee CN , Lin HH. Comparison of vascularization and overall perfusion of the bladder wall between women with and without overactive bladder syndrome. Scientific Reports. 2020;10:7549 (IF = 4.011; R/C = 15/69)
  37. Wang HH, Chen PM, Lin CL, Jau RC, Hsiao SM*, Ko JL. Joint effects of risk factors on adverse eventsassociated with adult blood donations. Medicine. 2020;98:44:1-9. (IF = 1.870; R/C =69/160)
  38. Chen HH, Chou YH, Lin HH, Hsiao SM*. Disastrous delayed postpartum hemorrhage after 3 days of Shenghua decoction treatment. Tzu Chi. Medical J.  2020;32(3):298-300.
  39. Hsiao SM, Chang TC, Wu PC, Lin HH*.  Predictors of an improvement in the severity of concomitant urodynamic stress incontinence after transvaginal mesh surgery for pelvic organ prolapse. J Formos Med Assoc. 2020;119,917-24. (IF = 3.008; R/C = 42/165)
  40. Wu CJ, Ting WH, Lin HH, Hsiao SM*. Clinical and Urodynamic Predictors of Q-tip Test in Women with Lower Urinary Tract Symptoms. Int Neurourol J.  2020;24(1):52-8. (IF = 1.899; R/C = 49/80)
  41. Wu PC, Hsiao SM, Chen CH, Lin HH*. Comparison of the vault prolapse rate after vaginal hysterectomy with or without residual uterine ligament ligations: a retrospective cohort study. J Formos Med Assoc. 2020;119:805-12. (IF = 2.844; R/C = 35/160)
  42. Ting WH, Lin HH, Hsiao SM*. Factors predicting persistent ectopic pregnancy after laparoscopic salpingostomy or salpingotomy for tubal pregnancy: a retrospective cohort study. J MINIM INVAS GYN 2019;26:1036-43. (IF = 2.547; R/C = 25/83)
  43. Chang TC, Hsiao SM, Wu PC, Chen CH, Wu WY,  Lin HH*. Comparison of clinical outcomes between tailored transvaginal mesh surgery and native tissue repair for pelvic organ prolapse. J Formos Med Assoc. 2019;118:1623-32. (IF = 2.844; R/C = 35/160)
  44. Ting WH, Lin HH, Hsiao SM*. Manual versus Pump Infusion of Distending Media for Hysteroscopic Procedures: A Randomized Controlled Trial. Scientific reports 2019;9:14943. (IF = 4.011; R/C = 15/69)
  45. Wu CJ, Ting WH, Lin HH, Hsiao SM*. Clinical and Urodynamic Predictors of Q-tip Test in Women with Lower Urinary Tract Symptoms. Int Neurourology J. 2019 (accept).  (IF = 1.899; R/C = 49/80)
  46. Liu HM, Lin HH,  Hsiao SM*. Impairment of urethral coitus due to mid-urethral sling in a woman with vaginal agenesis. Int Urogynecol J. 2019;30:1383-5.  (IF = 2.094; R/C = 38/83)
  47. Hsiao SM, Chang TC, Lin HH*. Comparisons of Re-treatment Probability after Discontinuation of 3-month versus 6-month Solifenaction for Female Overactive Bladder: A Prospective Randomized Controlled Study. Maturitas 2019;126:11-7.  (IF = 3.654; R/C = 9/83)
  48. Hsiao SM, Wu PC, Chang TC, Chen CH, Lin HH*. Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison with Overactive Bladder-dry. Int Neurourology J. 2019;23:69-74.  (IF = 1.726; R/C = 50/76)
  49. Chen HH, Ting WH, Lin HH,  Hsiao SM*. Predictors of Lymphoceles in Women Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecologic Cancer: A Retrospective Cohort Study. Int J Environ Res Public Health 2019;16:1-11.  (IF = 2.145; R/C = 42/117)
  50. Chen PL, Lin HH, Hsiao SM*. Predictors of subsequent pregnancy in women who underwent laparoscopic cornuostomy or laparoscopic wedge resection for interstitial pregnancy. J Chin Med Assoc. 2019;82:138-42. (IF = 1.660; R/C = 72/155)
  51. Sun HD, Hsiao SM, Yang ST, Cheng NM, Wang PH*. Aortic dissection in the third trimester pregnancy without risk factors. Taiwan J Obstet Gynecol 2019;58:723-4.  (IF = 1.200; R/C = 70/83)
  52. Liu YJ, Wu WY, Hsiao SM, Ting WH, Hsu HP, Huang CM*. Efficacy of pelvic floor training with surface electromyography feedback for female stress urinary incontinence. Int. J. Nurs. Pract. 2018 (accept). (IF = 1.142; R/C = 65/118)
  53. Hsiao SM, Lin HH*. Impact of the mid-urethral sling for stress urinary incontinence on female sexual function and their partners’ sexual activity. Taiwan J Obstet Gynecol 2018;57:853-7. (IF = 1.029; R/C = 72/82)
  54. Hsiao SM, Chang TC, Chen CH, Li YI, Shun CT, Lin HH*. Risk factors for coexistence of cervical elongation in uterine prolapse. Eur J Obstet Gynecol Reprod Biol 2018;229:94-7. (IF = 1.809; R/C = 50/82)
  55. Chen YC, Lin HH, Hsiao SM*. Comparison of Robotic Assisted Laparoscopic Myomectomy with Barbed Sutures and Traditional Laparoscopic Myomectomy with Barbed Sutures.  Taiwan J Obstet Gynecol 2018;57:709-12.  (IF = 1.029; R/C = 72/82)
  56. Chan LM, Lin HH, Hsiao SM*. Successful treatment of maternal Listeria monocytogenes bacteremia in the first trimester of pregnancy: a case report and literature review. Taiwan J Obstet Gynecol 2018;57:462-3.  (IF = 0.925; R/C = 73/80)
  57. Hsiao SM, Lin HH, Kuo HC*. Treatment outcome of overactive bladder patients receiving antimuscarinic therapy for more than one year. LUTS 2018;10:21-6. (IF = 0.302; R/C = 76/77)
  58. Hsiao SM,Lin HH*. Medical treatment of female overactive bladder syndrome and treatment-related dffects. J Formos Med Assoc 2018;117:871-8. (IF = 2.452; R/C = 42/155)
  59. Sun HD, Horng HC, Liu CH, Hsiao SM, Chen YJ, Chang WH, Wang PH. Comparison of single-port and three-port laparaoscopic salpingectomy in the management for tubal pregnancy. Journal of the Chinese Medical Association 2018;81:469-74. (IF = 1.252; R/C = 82/154)
  60. Hsiao SM,Chang TC, Chen CH, Wu WY, Lin HH*. Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study. LUTS 2018;10:215-20. (IF = 1.038; R/C = 66/76)
  61. Hsiao SM, Lin HH, Kuo HC*. Videourodynamic Studies of Women with Voiding Dysfunction. Sci Rep 2017;7:6845. (IF = 4.259; R/C = 10/64)
  62. Tsai KH, Hsiao SM, Lin HH.* Tolterodine treatment of women with overactive bladder syndrome: Comparisons of nighttime versus daytime dosing for nocturia. J Obstet Gynecol Re 2017;43:1719-25.  (co-first author) (IF = 0.611; R/C = 75/80)
  63. Ting WH, Lin HH, Hsiao SM.* Spontaneous Transvaginal Ileum Evisceration: A Case Report. Int Urogynecol J 2017;28:1107-8. (IF = 1.834; R/C = 41/80)
  64. Tien YW, Hsiao SM, Lee CN, Lin HH. Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function. Int Urogynecol J 2017;28:469-76. (IF = 1.834; R/C = 41/80)
  65. Hsiao SM, Lin HH, Kuo HC. Urodynamic prognostic factors for large post-void residual urine volume after intravesical injection of onabotulinumtoxinA for overactive bladder. Sci Rep 2017; 7:43753 (IF: 5.228, Ranking: 7/63)
  66. Chen MW, Yang ST, Chien MH, Hua KT, Wu CJ, Hsiao SM, Lin H, Hsiao M, Su JL, Wei LH*. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer. Cancer Res 2017;77:1955-67. (IF = 9.130, R/C = 17/223)
  67. Tu FC, Sun HD, Ting WH, Wu WY, Lin HH, Hsiao SM. Optimising laparoscopically extracorporeal knot tying using a novel pusher device. Surg Laparo Endo Per 2017 ;27:e31-5. (IF = 1.019; R/C = 138/200)
  68. Hsiao SM, Chang TC, Chen CH, Wu WY, Lin HH*. Frequent nocturia episodes, a suboptimal response to treatment and small bladder capacity predict the need for persistent antimuscarinic therapy or re-treatment after discontinuation of antimuscarinics in female overactive bladder. Menopause 2017;24:100-4. (IF = 3.172; R/C = 10/80)
  69. Ting WH, Peng FS, Lin HH, Hsiao SM. The impact of situation-background-assessment-recommendation (SBAR) on safety attitudes in the obstetrics department.Taiwan J Obstet Gyne 2017;56:171-4. (IF = 0.865; R/C = 71/80)
  70. Chen PL, Jhuang JY, Lin HH, Hsiao SM*. Successful treatment of gestational trophoblastic neoplasia in the uterine cornus with laparoscopic cornuostomy and postoperative methotrexate injection: a case report. Taiwan J Obstet Gynecol 2017;56:261-3. (IF = 0.865; R/C = 71/80)
  71. Chen MW, Yang ST, Chien MH, Hua KT, Wu CJ, Hsiao SM, Lin H, Hsiao M, Su JL, Wei LH*. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer. Cancer Res 2017;77:1955-1967.
  72. Tien YW#, Hsiao SM#, Lee CN, Lin HH*. Pad weight, urodynamic and sexual function effects of laser procedure for female urodynamic stress incontinence. Int Urogynecol J 2016 (accepeted) (IF = 1.834; R/C = 33/80, OBSTETRICS & GYNECOLOGY)
  73. Chen CH, Hsiao SM, Chang TC, Wu WY, Lin HH. Clinical and urodynamic effects of baclofen treatment in women with functional bladder outlet obstruction: a preliminary report. J OBSTET GYNAECOL RE, 2016 (42), 560-565. (IF = 1.072; R/C = 66/79)
  74. Chen JR, Chang TC, Fu HC, Lau HY, Chen IH, Ke YM, Liang YL, Chiang AJ, Huang CY, Chen YC, Hong MK, Wang YC, Huang KF, Hsiao SM, Wang PH. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG–2005) Retrospective Cohort Study (A STROBE-Compliant Article). Medicine, 2016;95(15):e3330, 1-11. (IF = 5.723; R/C = 15/154) 
  75. Hsiao SM, Lin HH, Kuo HC. Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA injection for Overactive Bladder Syndrome. PLOS ONE, 2016;11(1):e0147137, 1-13. (IF = 3.234; R/C = 9/57)
  76. Peng FS, Lin HM, Lin HH, Tu FC, Hsiao CF, Hsiao SM*. Impact of Clinical Audits on Cesarean Section Rate. Taiwan J Obstet Gynecol.  2016;55:530-3. (IF = 0.865; R/C = 71/80)
  77. Tu FC, Sun HD, Chuang YC, Wu WY, Lin HH, Hsiao SM*. Integrating both Laparoscopically Intracorporeal Suturing and Knot Tying into a Single Procedure Using a Novel Knotting Device. J AM COLL SURGEONS, 2015;220(1):e1-5 (IF = 4.454; R/C = 9/204)
  78. Hsiao SM, Liao CH, Lin HH, Kuo HC. Duration of antimuscarinic administration for treatment of overactive bladder before which one can assess efficacy: An analysis of predictive factors. Int Neurourol J 2015;19:171-7. (IF = 1.061; R/C = 60/78)
  79. Chang TC, Hsiao SM, Chen CH, Wu WY, Lin HH. Clinical Outcomes and Urodynamic Effects of Tailored Transvaginal Mesh Surgery for Pelvic Organ Prolapse. Biomed Res Int 2015;191258:1-9. (IF = 1.579; R/C = 107/163)
  80. Sun HD, Hsiao SM, Chen YJ, Wen KC, Li YT, Wang PH*.Advanced endocervical adenocarcinoma metastatic to the ovary presenting as primary ovarian cancer. Taiwan J Obstet Gynecol 2015;54(2):201-3. (IF = 0.988; R/C = 68/79)
  81. Sun HD, Hsiao SM, Wen KC, Wang PH*. Isolated Krukenberg tumor in pregnancy. Taiwan J Obstet Gynecol 2015;54(2):211-2. (IF = 0.988; R/C = 68/79)
  82. Ting WH, Peng FH, Lin HH, Lu HF, Hsiao SM*. Factors Influencing the Abortion Interval of Second Trimester Pregnancy Termination Using Misoprostol. Taiwan J Obstet Gynecol 2015;54:408-11. (IF = 0.988; R/C = 68/79)
  83. Ting WH, Lin HH, Wu MP, Tu FC, Peng FS, Hsiao SM*.Safety and efficacy of manual syringe infusion of distending media for hysteroscopic procedures: a case-control study. Eur J Obstet Gynecol Reprod Biol 2015;191:112-5. (IF = 1.695; R/C = 44/79)
  84. Chen YY, Peng FS, Lin HH, Hsiao SM*. Gastrointestinal stromal tumor mimicking ovarian malignancy in a women with Type I neurofibromatosis. Taiwan J Obstetric & Gynecology. 2015;54:330-1. (IF = 0.988; R/C = 68/79)
  85. Hsiao SM#, Chen MW, Chen CA, Chien MH, Hsiao Michael, Kuo ML, Wei LH*. The H3K9 Methyltransferase G9a Represses E-cadherin and Is Associated with Myometrial Invasion in Endometrial Cancer. Ann Surg Oncol. 2015;22:1556-65. (co-first author)  (IF = 3.930; R/C = 15/198)
  86. Hsiao SM, Liao SC, Chen CH, Chang TC, Lin HH. Psychometric assessment of female overactive bladder syndrome and antimuscarinics-related effects. Maturitas. 2014;79:428-34. (SCI) (IF = 3.255; R/C = 11/80)
  87. Wu CJ, Tong YC, Hsiao SM, Liang CC, Liang SJ, Weng SF, Wu MP. The surgical trends and time-frame comparison of primary surgery for stress urinary incontinence, 2006-2010 vs 1997-2005: a population-based nation-wide follow-up descriptive study. Int Urogynecol J. 2014;25:1683-91. (SCI)
  88. Hsiao SM, Su TC, Chen CH, Chang TC, Lin HH. Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects. Maturitas 2014 Sep;79(1):65-9. 
  89. Chang TC, Hsiao SM, Chen CH, Wu WY, Lin HH*.Utilizing preoperative 20-minute pad testing with vaginal gauze packing for indicating concomitant midurethral sling during cystocele repair. EUR J OBSTET GYN R B. 2014 ;172:127-30. (co-first author)（SCI）
  90. Hsiao SM, Lin HH, Kuo HC*. Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome. Neurourol Urodyn 2014;33:331-4. (SCI)
  91. Hsiao SM, Lin HH, Peng FS, Jen PJ, Hsiao CF, Tu FC.Comparison of robot-assisted laparoscopic myomectomy and traditional laparoscopic myomectomy. J Obstet Gynaecol Res 2013 (in press) (SCI)
  92. Hsiao SM, Lin HH, Kuo HC. International prostate symptom score for assessing lower urinary tract dysfunction in women.Int Urogynecol J 2013;24:263-7 (SCI)
  93. Chang TC, Chang SR, Hsiao SM, Hsiao CF, Chen CH, Lin HH. Factors associated with fecal incontinence in women with lower urinary tract symptoms.J Obstet Gynaecol Res 2013;39:250-5 (SCI)
  94. Chen YY, Hsiao SM, Hsu YP, Lin HH, Wei MC*. Borderline mucinous ovarian tumor Presenting as pseudo-Meigs’ syndrome. J Obstet Gynecol Res 2013:39:434-6 (SCI)
  95. Hsieh CH*, Tien HJ, Hsiao SM, Wei MC, Wu WY, Sun HD, Wang LY, Hsieh YP, Chen YJ, Shueng PW. Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients - a preliminary result. Onco Targets Ther 2013;6:59-66.
  96. Hsieh CH, Shueng PW, Hsiao SM, Wei MC, Wu WY, Sun HD, Tien HJ, Wang LY, Hsieh YP. Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma.Onco Targets Ther 2012;5:245-53
  97. Hsiao SM, Lin HH, Kuo HC*. The role of serum C-reactive protein in women with lower urinary tract symptoms. Int Urogynecol J 2012;23:935-40 (SCI)
  98. Tu FC, Wu WY, Lin HH, Hsiao SM*. Laparoscopic intracorporeal knot tying using a novel device. Surg Endosc2012;26:872-6 (SCI)
  99. Sun HD, Tsai CC, Hsiao SM, Wei MC, Wang KC, Wang PH. Primary gallbladder carcinoma presenting as advanced-stage ovarian cancer. Taiwan J Obstet Gynecol2012;51:443-5
  100. Hsiao SM, Chang TC, Wu WY, Chen CH, Lin HH*. Inserting the tunneller during an outside-in transobturator tape procedure by syringe-needle guidance. J Obstet Gynaecol 2011;31:524-28 (SCI)
  101. Hsiao SM, Chang TC, Wu WY, Chen CH, Yu HJ, Lin HH*. Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome. J Obstet Gynaecol Res 2011;37:1084-91 (SCI)
  102. Wu MC, Hsu YP, Lin HH, Hsiao SM*. Severe delayed postpartum hemorrhage due to a neglected uterine diverticulum. J Reprod Med 2011 (accept)(SCI)
  103. Hsiao SM, Wei LH*. Controversies in the adjuvant therapy of endometrial cancer. ISRN Obstet Gynecol 2011;2011:724649
  104. Hung HC, Hsiao SM, Chih SY, Lin HH*, Tsauo JY. Effect of pelvic-floor muscle strengthening on bladder neck mobility: a clinical trial. Phys Ther 2011;91:1030-38 (SCI)
  105. Wu MC, Huang WC, Lin HH, Hsiao SM*. Severe intra-abdominal bleeding from neglected omental implantation of ectopic tissue after methotrexate treatment for persistent ectopic pregnancy. Fertil Steril 2011;95:2435 e1-3 (SCI)
  106. Wu WY, Hsiao SM, Chang TC, Lin HH*. Changes in urodynamic parameters after tolterodine treatment for female overactive bladder syndrome with or without voiding dysfunction. J Obstet Gynaecol Res 2011;37:436-41 (SCI)
  107. Wei LH, Torng PL, Hsiao SM, Jeng YM, Chen MW, Chen CA*. Histone deacetylase 6 regulates estrogen receptor {α} in uterine leiomyoma. Reprod Sci 2011;18:755-62 (SCI)
  108. Lo CW, Chen MW, Hsiao M, Wang S, Chen CA, Hsiao SM, Chang JS, Lai TC, Stefan RJ, Kuo ML, Wei LH*. IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res 2011;71:424-34 (SCI)
  109. Chen CH, Hsiao SM, Chang TC, Wu WY, Lin HH*. Transvaginal cystocele repair using pursestring technique reinforced with custom-tailored two-armed mesh. Urology 2011;78:1275-80(SCI)
  110. Hung HC, Hsiao SM, Chih SY, Lin HH, Tsauo JY*. An alternative intervention for urinary incontinence: retraining diaphragmatic, deep abdominal and pelvic floor muscle coordinated function. Man Ther 2010;15:273-79 (SCI)
  111. Hsieh CH, Wei MC, Hsu YP, Chong NS, Chen YJ, Hsiao SM, Hsieh YP, Wang LY, Shueng PW*. Should helical tomotherapy replace brachytherapy for cervical cancer? Case report. BMC Cancer 2010;10: 637 (SCI)
  112. Hsieh CH, Wei MC, Lee HY, Hsiao SM, Chen CA, Wang LY, Hsieh YP, Tsai TH, Chen YJ, Shueng PW*. Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapy.Radiat Oncol 2009;4:62 (SCI)
  113. Lin CC, Ou MC, Hsiao SM, Lin HH*. Myomectomy through the uterine cervix using forceps under sonographic guidance.Ultrasound Obstet Gynecol 2009;33:228-31 (SCI)
  114. Hsiao SM, Chen CA, Lin HH, Hsieh CY, Wei LH*. Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox(R)) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum.Gynecol Oncol 2009;112:35-9(SCI)
  115. Hsiao SM, Chang TC, Lin HH*. Reply by the authors. Urology 2009;74:1379-80 (SCI)
  116. Hsiao SM, Chang TC, Lin HH*. Risk factors influencing cure after midurethral tape procedures for female urodynamic stress incontinence: comparison of retropubic and transobturator routes. Urology 2009;73:981-6 (SCI)
  117. Chen YL, Hsiao SM, Lin MC, Lin HH*. Bone metastasis as initial presentation in one case of ovarian cancer with two components of endometrioid adenocarcinoma and adenosarcoma. Taiwan J Obstet Gynecol 2009;48:298-301 (SCI)
  118. Hsiao SM, Chen CA, Hsu C, Lin HH, Hsieh CY, Wei LH*. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma. Anticancer Res 2008;28:1887-91 (SCI)
  119. Hsiao SM, Chang TC, Chen CH, Lin HH*. Sequential comparisons of postoperative urodynamic changes between retropubic and transobturator midurethral tape procedures.World J Urol 2008;26:643-8 (SCI)
  120. Hsiao SM, Sheu BC, Lin HH*. Sequential assessment of urodynamic findings before and after transobturator tape procedure for female urodynamic stress incontinence. Int Urogynecol J 2007;19:627-32 (SCI)
  121. Hsiao SM, Wu MH, Jou HJ, Lee CN, Shyu MK, Shih JC, Hsieh FJ*.Outcome for fetuses with prenatally detected congenital heart disease and cardiac arrhythmias in Taiwan. J Formos Med Assoc 2007;106:423-31 (SCI)
  122. Chen CW, Hsiao SM, Chen CA, Hsieh CY, Cheng WF*.Clear cell adenocarcinoma of the uterine cervix. Taiwan J Obstet Gynecol 2007;46:453-5 (SCI)
  123. Hsiao SM, Hsieh FJ, Lien YR.Tuboovarian abscesses in postmenopausal women. Taiwan J Obstet Gynecol 2006;45:234-8 (SCI)
  124. Shih JC, Peng SS, Hsiao SM, Wang JH, Shyu MK, Lee CN, Hsieh FJ.Three-dimensional ultrasound diagnosis of Larsen syndrome with further characterization of neurological sequelae. Ultrasound Obstet Gynecol 2004;24:89-93 (SCI)
  125. Hsiao SM, Lee LC, Chang MH. Large pelvic accessory spleen mimicking an adnexal malignancy in a teenage girl.J Formos Med Assoc 2001;100:565-7 (SCI)
  126. Hsiao SM, Wu MH, Shih JC, Hsieh FJ. In utero progressive pulmonary stenosis successfully treated with transcatheter intervention after delivery.J Formos Med Assoc 2001;100:347-9 (SCI)
TOP
Copyright © 亞東醫院婦產部官網 All Rights Reserved.